Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neutralization of HIV-1

H Golding1, M P D'Souza, J Bradac

  • 1Laboratory of Retrovirus Research, FDA/CBER, Bethesda, Maryland 20892.

AIDS Research and Human Retroviruses
|June 1, 1994
PubMed
Summary

Researchers convened to standardize HIV-1 neutralization assays for vaccine development. The workshop focused on identifying key assays and reagents to evaluate the efficacy of prophylactic vaccines in clinical trials.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2021 Canadian Surgery Forum: Virtual, online Sept. 21-24, 2021.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis.

Virus evolution·2017
Same author

Heterogeneity of HIV incidence: a comparative analysis between fishing communities and in a neighbouring rural general population, Uganda, and implications for HIV control.

Sexually transmitted infections·2016
Same author

Pregnancy rates among female participants in phase I and phase IIA AIDS vaccine clinical trials in Kenya.

East African medical journal·2011
Same author

Optical radiation hazards analysis of ultraviolet headlamps.

Applied optics·2010
Same author

Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers.

Vaccine·2008

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • The development of effective Human Immunodeficiency Virus type 1 (HIV-1) prophylactic vaccines is a global health priority.
  • Standardized methods are crucial for evaluating vaccine efficacy in clinical trials.
  • Existing neutralization and binding assays for immune sera require critical assessment and standardization.